Southampton research could lead to better treatments for cardiovascular disease
2012-04-04
(Press-News.org) Scientists at the University of Southampton have discovered a new process that controls the ability of arteries to regulate blood pressure.
Arteries are able to control blood pressure by relaxing and constricting. In healthy people, the ability of arteries to relax or constrict is kept in balance. However, this balance shifts in people who are at risk of developing high blood pressure or atherosclerosis. There is more constriction within the arteries so blood cannot flow freely increasing the risk of heart attacks and stroke.
Researchers in Southampton, led by Dr Graham Burdge, Reader in Human Nutrition, have identified a new process that controls the ability of arteries to constrict, which could lead to a better understanding of the causes of cardiovascular disease and the development of new treatments.
In a study funded by the British Heart Foundation, which is published in PLoS ONE today (3 April 2012), researchers showed that polyunsaturated fats, which are converted into fat-like molecules called eicosanoids in order to make arteries constrict, are made by the muscle cells in the arteries rather than being taken up from blood, as previously thought.
By blocking the action of two enzymes that create polyunsaturated fats, the researchers were able to reduce the constriction of arteries allowing blood to flow more freely, therefore lowering the risk of high blood pressure.
The research also found that this process changed in arteries that showed the early signs of causing high blood pressure. They found changes in the epigenetic 'switches' that control one of the key genes for making polyunsaturated fats, while another gene over-compensated for this change.
Dr Burdge comments: "This is an important finding. Cardiovascular disease is an increasing public health issue. In 2009, over 180,000 people died from cardiovascular disease in the UK – that is one in three of all deaths.
"Discovering a new process which controls how arteries work, and finding that it can be modified in the laboratory, raises a strong possibility for developing new medicines that may lead to better ways of treating cardiovascular disease. Currently, it is difficult for doctors to screen people at risk of cardiovascular disease before symptoms develop. However, a test based on the epigenetic changes we have found could provide a new way of screening people for risk of cardiovascular disease, and, in time, it might also be possible to correct this epigenetic defect."
INFORMATION: END
ELSE PRESS RELEASES FROM THIS DATE:
2012-04-04
April in Israel is a month with many special events including: festivals, concerts, performances, street fairs and walking tours which are tremendously varied so that there is something for every one of all ages and tastes. April's warm temperatures mean that more outdoor events can take place, and combined with the Passover holiday for which kids are away from school, it means that April is a great time to be in Israel. Additionally, as the local holiday coincides with the Easter holiday, many Christian tourists choose to visit Israel in April, as the majority of them ...
2012-04-04
Research: The risk of cancer in the first seven years after metal-on-metal hip replacement compared with other bearings and the general population: a linkage study between the National Joint Registry of England and Wales and Hospital Episode Statistics
Patients who have had metal-on-metal hip replacements are no more likely to develop cancer in the first seven years after surgery than the general population, although a longer-term study is required, a study published on bmj.com today claims.
A recent BMJ and BBC Newsnight investigation looked into the potentially high ...
2012-04-04
Neonatal services in England have seen a considerable improvement since the introduction of new guidelines in 2003, a study published on bmj.com claims.
The new guidelines were set out to help increase the proportion of premature babies born in a specialist care unit and reduce the amount of acute (within 24 hours of birth) postnatal transfers from one hospital to another. The specialised delivery and management of premature babies is associated with improved outcomes while acute postnatal transfer is associated with adverse outcomes.
Researchers from the Imperial ...
2012-04-04
CHICAGO— Hepatitis B-infected patients with significantly longer telomeres—the caps on the end of chromosomes that protect our genetic data— were found to have an increased risk of getting liver cancer compared to those with shorter ones, according to findings presented by researchers at Jefferson's Kimmel Cancer Center at the American Association for Cancer Research (AACR) Annual Meeting 2012.
The relative telomere length in hepatitis B-infected cases with liver cancer was about 50 percent longer than the telomere length of the cancer-free hepatitis B-infected controls.
A ...
2012-04-04
ROCHESTER, Minn. -- The dietary supplement gamma-linoleic acid can inhibit the growth of a
subset of pancreatic cancer cells and selectively promote cancer cell death in mice, a Mayo Clinic study has found. The supplement, a fatty acid also known as GLA, worked particularly well when combined with the chemotherapy drug gemcitabine, the researchers say. The findings were presented today by Mayo Clinic pathologist Ruth Lupu, Ph.D., at the American Association for Cancer Research (AACR) Annual Meeting 2012. "One of the most devastating facts about pancreatic cancer is the ...
2012-04-04
Sonic Games 365, a big player in the free gaming universe is now offering even more Adobe Flash games that incorporate beloved Sega characters such as Sonic, Tails, Knuckles, Amy and more. Sonic Games 365 has these added four brand new titles to its line-up: Sonic Spin Break, Sonic's Crazy Coin Collect, Sonic Rolling Ball, and Super Mario Save Sonic. These four games are all about promoting the true meaning of Sonic Games 365, which has been from day one to always have the largest selection of games featuring, feature everybody's favorite blue hedgehog, and never charge ...
2012-04-04
ROCHESTER, Minn. -- A study presented today by Mayo Clinic researchers at the American Association for Cancer Research (AACR) Annual Meeting 2012 in Chicago identified two genes that are optimal targets to be analyzed in a new noninvasive test for colorectal cancer developed by Mayo Clinic, in collaboration with Exact Sciences Corporation. The test uses a small sample of a patient's stool to check for specific DNA changes, known as gene methylation, that occur as cancer develops. The test can quickly detect both early stage cancer and precancerous polyps.
"This study ...
2012-04-04
OTTAWA, Canada -- Dr. Roger Zemek, Director of Emergency Research at the CHEO Research Institute and ED physician, and assistant professor in the Faculty of Medicine at the University of Ottawa, has overseen the creation and implementation of a Medical Directive that now empowers nurses to administer an oral steroid treatment, which has reduced wait time and improved patient care. This research is published today in Pediatrics.
Asthma is the most common chronic illness in children requiring a visit to Emergency. Every year, the Children's Hospital of Eastern Ontario (CHEO) ...
2012-04-04
CHICAGO --- A new drug developed by Northwestern Medicine scientists prevented human prostate cancer cells from spreading to other tissues without any toxic effects to normal cells or tissues. The drug turns off the "go" switch in the cancer cells and immobilizes them.
Prostate cancer is the second-leading cause of cancer death in North American males. Death is mainly caused by metastasis, prostate cancer cells moving out of prostate tissue and spreading to other organs.
"This is an extremely promising new therapeutic that locks down aggressive prostate cancer cells ...
2012-04-04
SAN FRANCISCO, CA—April 3, 2012—Scientists at the Gladstone Institutes have enhanced our understanding of how a protein linked to Alzheimer's disease keeps young brains healthy, but can damage them later in life—suggesting new research avenues for treating this devastating disease.
In the Journal of Neuroscience, available online today, researchers in the laboratory of Yadong Huang, MD, PhD, have uncovered the distinct roles that the apoE protein plays in young vs. aging brains. These findings, which could inform the future of Alzheimer's drug development, come at a time ...
LAST 30 PRESS RELEASES:
[Press-News.org] Southampton research could lead to better treatments for cardiovascular disease
